Cargando…
Adjuvant radiotherapy for pathological high-risk muscle invasive bladder cancer: time to reconsider?
Radical cystectomy with extended pelvic lymph-node dissection, associated with neo-adjuvant chemotherapy, remains the standard of care for advanced, non-metastatic muscle-invasive bladder cancer (MIBC). Loco-regional control is a key factor in the outcome of patients since it is related to overall s...
Autores principales: | Sargos, Paul, Baumann, Brian C., Eapen, Libni J., Bahl, Amit, Murthy, Vedang, Roubaud, Guilhem, Orré, Mathieu, Efstathiou, Jason A., Shariat, Shahrokh, Larré, Stephane, Richaud, Pierre, Christodouleas, John P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071208/ https://www.ncbi.nlm.nih.gov/pubmed/27785427 http://dx.doi.org/10.21037/tau.2016.08.18 |
Ejemplares similares
-
The Rationale for Post-Operative Radiation in Localized Bladder Cancer
por: Baumann, Brian C., et al.
Publicado: (2017) -
Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study
por: Orré, Mathieu, et al.
Publicado: (2017) -
Single-Center Experience of Focal Thermo-Ablative Therapy After Pelvic Radiotherapy for In-Field Prostate Cancer Oligo-Recurrence
por: Giraud, Nicolas, et al.
Publicado: (2021) -
Chromogranin A: a useful biomarker in castration-resistant prostate cancer
por: Ploussard, Guillaume, et al.
Publicado: (2022) -
Oncologic Impact and Safety of Pre-Operative Radiotherapy in Localized Prostate and Bladder Cancer: A Comprehensive Review from the Cancerology Committee of the Association Française d’Urologie
por: Sargos, Paul, et al.
Publicado: (2021)